The Medication-use Evaluation (MUE)
Unit monitors drug utilisation and patient outcomes following treatment. This
process is conducted on medications on the Government Formulary List (GFL),
newly introduced drugs and non-formulary drugs currently being approved through
the Exceptional Medicinal Treatment (EMT)
Policy.
MUE is focused on evaluating and
improving medication-use processes with the goal of achieving optimal patient
outcomes. The process consists of a formal evidence-based analysis aimed
to assist stakeholders in determining efficiencies
and identify opportunities for change.
Results and recommendations of the
MUE are submitted to health authorities and stakeholders as required.
